Talk:Oxford–AstraZeneca COVID-19 vaccine
This is the talk page for discussing improvements to the Oxford–AstraZeneca COVID-19 vaccine article. This is not a forum for general discussion of the article's subject. |
Article policies
|
Find medical sources: Source guidelines · PubMed · Cochrane · DOAJ · Gale · OpenMD · ScienceDirect · Springer · Trip · Wiley · TWL |
Archives: Index, 1, 2Auto-archiving period: 30 days |
This article is written in British English, which has its own spelling conventions (colour, travelled, centre, defence, artefact, analyse) and some terms that are used in it may be different or absent from other varieties of English. According to the relevant style guide, this should not be changed without broad consensus. |
This article is rated B-class on Wikipedia's content assessment scale. It is of interest to the following WikiProjects: | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
Daily pageviews of this article
A graph should have been displayed here but graphs are temporarily disabled. Until they are enabled again, visit the interactive graph at pageviews.wmcloud.org |
The contentious topics procedure applies to this page. This page is related to COVID-19, broadly construed, which has been designated as a contentious topic. Editors who repeatedly or seriously fail to adhere to the purpose of Wikipedia, any expected standards of behaviour, or any normal editorial process may be blocked or restricted by an administrator. Editors are advised to familiarise themselves with the contentious topics procedures before editing this page. |
Ideal sources for Wikipedia's health content are defined in the guideline Wikipedia:Identifying reliable sources (medicine) and are typically review articles. Here are links to possibly useful sources of information about Oxford–AstraZeneca COVID-19 vaccine.
|
Nanoparticles?
editDoes it use nanoparticles? — Preceding unsigned comment added by 73.38.189.222 (talk) 20:02, 4 November 2022 (UTC)
- This page is not a forum to discuss the topic. It does insofar as a virus is a nanoparticle; viral vector vaccine. Pabsoluterince (talk) 21:59, 4 November 2022 (UTC)
- We're talking about nanoparticle lipids obviously. So, does it use nanoparticles? — Preceding unsigned comment added by 73.38.189.222 (talk) 22:03, 4 November 2022 (UTC)
- The virus it uses as a vector is an adenovirus, which is nonenveloped, meaning it doesn't have a lipid envelope (unlike enveloped viruses, like the coronavirus). Which means the answer is no. 188.159.240.15 (talk) 13:34, 1 May 2024 (UTC)
- We're talking about nanoparticle lipids obviously. So, does it use nanoparticles? — Preceding unsigned comment added by 73.38.189.222 (talk) 22:03, 4 November 2022 (UTC)
Verifiability issues
editIt's in category "Withdrawn drugs" but I can't find any sourced content in the article regarding its alleged withdrawal. (t · c) buidhe 04:37, 2 December 2023 (UTC)
- Nothing about it here,[1] and the implication is it's being used in parts of the world where the mRNA ones are tricky to store. Bon courage (talk) 05:20, 2 December 2023 (UTC)
- It has been banned in at least Australia. I'd assume the distinction between banned and withdrawn is to be made, as the manufacturer didn't make this decision. Moreover, I don't know how we treat that category when it has only been withdrawn from some markets (see Nefazodone for a similar instance for withdrawn from some markets and available in others).
- That being said, perhaps the category should be reassessed now. Kimen8 (talk) 17:17, 21 March 2024 (UTC)
Developer
editShould we change the developer from Oxford University to Jenner Institute? Pro translator (talk) 16:41, 21 March 2024 (UTC)
Apparently withdrawn in EU entirely now?
edithttps://ec.europa.eu/health/documents/community-register/2024/20240327162288/dec_162288_en.pdf Gigs (talk) 20:28, 6 May 2024 (UTC)
??
editReuters says: "AstraZeneca to withdraw COVID-19 vaccine globally, Telegraph reports". Big if true, I guess (?) jp×g🗯️ 21:24, 7 May 2024 (UTC)